Nobel Award Honors Pioneering Immune System Research

This year's Nobel Prize in Physiology or Medicine has been granted for transformative findings that clarify how the immune system targets dangerous pathogens while protecting the body's own cells.

A trio of renowned researchers—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—share this honor.

The research identified specialized "security guards" within the immune system that eliminate malfunctioning immune cells capable of attacking the body.

These discoveries are now paving the way for new treatments for autoimmune diseases and cancer.

The winners will share a monetary award worth 11 million SEK.

Crucial Findings

"Their research has been essential for comprehending how the body's defenses functions and why we don't all develop severe self-attack conditions," commented the chair of the award panel.

This trio's studies explain a fundamental mystery: In what way does the defense system defend us from countless infections while leaving our healthy cells intact?

Our body's protection system employs white blood cells that scan for indicators of infection, including viruses and germs it has never encountered.

These cells utilize sensors—called recognition units—that are generated randomly in a vast number of variations.

This provides the defense network the ability to fight a wide array of invaders, but the randomness of the process inevitably creates immune cells that can target the host.

Protectors of the Immune System

Scientists previously knew that some of these harmful defense cells were eliminated in the immune organ—the site where white blood cells mature.

The latest Nobel Prize honors the discovery of regulatory T-cells—known as the body's "peacekeepers"—which travel through the body to neutralize other defenders that assault the healthy cells.

We know that this process fails in autoimmune diseases such as juvenile diabetes, MS, and RA.

A prize committee added, "The findings have laid the foundation for a novel area of research and spurred the development of innovative treatments, for example for cancer and immune disorders."

In cancer, T-regs prevent the body from fighting the growth, so research are focused on lowering their numbers.

For autoimmune diseases, experiments are testing increasing regulatory T-cells so the body is no longer being harmed. A similar method could also be useful in minimizing the risks of organ transplant failure.

Innovative Studies

Prof Sakaguchi, of Osaka University, performed tests on rodents that had their thymus removed, causing autoimmune disease.

The researcher demonstrated that introducing defense cells from healthy animals could stop the disease—implying there was a system for blocking immune cells from harming the host.

Mary Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, now at a biotech firm in a California city, were investigating an inherited autoimmune disease in rodents and people that led to the discovery of a gene critical for how regulatory T-cells operate.

"Their pioneering work has uncovered how the immune system is controlled by regulatory T cells, preventing it from accidentally attacking the healthy cells," commented a leading biological science specialist.

"The research is a remarkable illustration of how fundamental physiological study can have broad consequences for public health."